Related Experiment Videos
Evidence for iNOS-dependent peroxynitrite production in diabetic platelets
M Tannous1, R A Rabini, A Vignini
1School of Physical Sciences, Chemistry and Biochemistry, University of Windsor, Ontario, Canada.
Diabetologia
|May 20, 1999
Summary
Diabetic platelets produce significantly more peroxynitrite than normal platelets, linked to inducible nitric oxide synthase. This indicates peroxynitrite contributes to platelet damage in diabetes.
Area of Science:
- Biochemistry
- Hematology
- Endocrinology
Background:
- Diabetes mellitus is associated with increased oxidative stress and platelet dysfunction.
- Platelet activation and aggregation play a crucial role in diabetic complications.
- Peroxynitrite is a reactive nitrogen species implicated in cellular damage.
Purpose of the Study:
- To investigate peroxynitrite production in diabetic platelets compared to normal platelets.
- To determine the correlation between peroxynitrite levels and inducible nitric oxide synthase (iNOS) expression in platelets.
- To elucidate the role of iNOS-derived peroxynitrite in diabetic platelet damage.
Main Methods:
- Measurement of intraplatelet peroxynitrite using dichlorofluorescin acetate with confocal microscopy and steady-state fluorescence.
- Quantification of peroxynitrite production as a function of L-arginine and nitric oxide synthase inhibitors.
- Detection of inducible nitric oxide synthase (iNOS) in platelets via western immunoblotting.
Main Results:
- Platelets from Type I and Type II diabetic subjects exhibited significantly higher peroxynitrite production compared to control subjects.
- Peroxynitrite production in diabetic platelets was dependent on L-arginine and sensitive to nitric oxide synthase inhibitors.
- Inducible nitric oxide synthase (iNOS) was detected in platelets from diabetic patients (Type I and Type II) but absent in control subjects.
Conclusions:
- Inducible nitric oxide synthase (iNOS) is upregulated in diabetic platelets.
- iNOS-derived peroxynitrite is a significant contributor to platelet damage in diabetes.
- Targeting iNOS or peroxynitrite may offer therapeutic strategies for diabetic complications.